An Oxford-led study has demonstrated that an oral live-attenuated vaccine, CVD 1902, provided significant protection against S. Paratyphi A infection in healthy adults using a controlled human infection model, without any safety concerns. The research is published in the New England Journal of Medicine.
Study shows vaccine protection against Salmonella Paratyphi A infection
